Rchr
J-GLOBAL ID:202101007215212457   Update date: Feb. 19, 2024

Tsubata Yukari

Tsubata Yukari
Research field  (1): Respiratory medicine
Research keywords  (1): Medical Oncology, Lung cancer, Geriatric Oncology, Cardio-oncology
Research theme for competitive and other funds  (2):
  • 2016 - 2020 A Clinical study on activity of NAMPT and SIRT1 gene expression in neutropenia with cancer chemotherapy
  • 2015 - 2018 New therapeutic strategy for small-cell lung cancer
Papers (119):
  • Tadahiro Kuribayashi, Kadoaki Ohashi, Kazuya Nishii, Kiichiro Ninomiya, Yukari Tsubata, Nobuhisa Ishikawa, Masahiro Kodani, Nobuhiro Kanaji, Masahiro Yamasaki, Kazunori Fujitaka, et al. Clinical characteristics of patients treated with immune checkpoint inhibitors in EGFR-mutant non-small cell lung cancer: CS-Lung-003 prospective observational registry study. Journal of cancer research and clinical oncology. 2024. 150. 2. 89-89
  • Ryosuke Tanino, Yukari Tsubata, Takamasa Hotta, Tamio Okimoto, Yoshihiro Amano, Mayumi Takechi, Tetsuya Tanaka, Tomomi Akita, Mamiko Nagase, Chikamasa Yamashita, et al. Characterization of a spontaneous mouse model of mild, accelerated aging via ECM degradation in emphysematous lungs. Scientific reports. 2023. 13. 1. 10740-10740
  • Misato Kobayashi, Noriaki Kurimoto, Ryosuke Tanino, Yohei Shiratsuki, Takae Okuno, Mika Nakao, Takamasa Hotta, Yukari Tsubata, Makoto Nagasaki, Takashi Nishisaka, et al. Comparison of Ultra-Magnifying Endocytoscopic and Hematoxylin-Eosin-Stained Images of Lung Specimens. Diagnostics (Basel, Switzerland). 2023. 13. 5
  • Ryota Saito, Shunichi Sugawara, Ryo Ko, Koichi Azuma, Ryo Morita, Makoto Maemondo, Satoshi Oizumi, Kazuhisa Takahashi, Hiroshi Kagamu, Yukari Tsubata, et al. Phase 2 study of osimertinib in combination with platinum and pemetrexed in patients with previously untreated EGFR-mutated advanced non-squamous non-small cell lung cancer: The OPAL Study. European journal of cancer (Oxford, England : 1990). 2023. 185. 83-93
  • 天野 芳宏, 沖本 民生, 幡 高次郎, 中島 和寿, 濱口 愛, 津端 由佳里, 礒部 威. 非小細胞肺癌の骨転移に対して緩和的放射線治療をおこなった患者の予後予測スコアの検証. 日本呼吸器学会誌. 2023. 12. 増刊. 282-282
more...
MISC (235):
  • 津端 由佳里. 治療法の再整理とアップデートのために 専門家による私の治療 胸膜腫瘍(悪性胸膜中皮腫を含む). 日本医事新報. 2022. 5100. 40-40
  • 津端 由佳里. 【老年腫瘍学】高齢者を対象とした臨床試験 試験結果を日常臨床に外挿するために. 癌と化学療法. 2022. 49. 1. 19-23
  • 奥野 峰苗, 津端 由佳里, 天野 芳宏, 濱口 愛, 濱口 俊一, 礒部 威. ニボルマブ適応外使用後のトラスツズマブ エムタンシン投与による重篤な薬剤性肺障害. 癌と化学療法. 2022. 49. 1. 71-73
  • 村上 航太朗, 天野 芳宏, 白築 陽平, 奥野 峰苗, 中尾 美香, 中島 和寿, 堀田 尚誠, 濱口 愛, 津端 由佳里, 礒部 威. 肺胞蛋白症合併肺腺癌stage IVBに対し、化学療法および免疫チェックポイント阻害薬を施行した1例. 肺癌. 2021. 61. 7. 1006-1006
  • 津端 由佳里. 【高齢者の悪性腫瘍-老年内科医としての診療】高齢がん患者における治療法選択のアプローチ. 老年内科. 2021. 4. 5. 464-471
more...
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page